Upadacitinib Shows Safety and Efficacy in Adolescents with Severe Alopecia Areata: Study Dr. Shravani Dali11 Sept 2025 8:15 PM ISTAlopecia areata (AA) is a chronic, immune-mediated disorder characterized by non-scarring hair loss, with profound psychological and social...
Baricitinib not linked to increased VTE Risk in Alopecia Areata Patients: Study Jacinthlyn Sylvia8 Sept 2025 8:30 PM ISTA new study published in the International Journal of Dermatology revealed that alopecia areata patients treated with baricitinib had no reported...
Alopecia Areata Linked to Autoimmune Thyroid Diseases, Suggests Study Medha Baranwal2 Sept 2025 8:45 PM ISTIsrael: Researchers have found, in a large-scale study, a significant association between alopecia areata and autoimmune thyroid diseases,...
Real-World Study Confirms Baricitinib's Effectiveness for Alopecia Areata Dr. Shravani Dali15 Aug 2025 9:30 PM ISTA recent real-world study conducted in China has confirmed that baricitinib, a Janus kinase (JAK) inhibitor, significantly improves hair regrowth in...
Vitiligo Causally Linked to Rheumatoid Arthritis, Type 1 Diabetes, and Alopecia Areata: Study Dr Riya Dave7 Aug 2025 8:30 PM ISTA new study published in the Journal of Cosmetic Dermatology has found that vitiligo has a direct causal relationship with a number of autoimmune...
Ritlecitinib effective against moderate to severe alopecia areata over long term: Study Jacinthlyn Sylvia5 Aug 2025 9:00 PM ISTA recent ALLEGRO-LT trial reported strong results on the use of ritlecitinib for treating alopecia areata (AA), characterized by patchy or total hair...
Sun Pharma net profit drops 20% to Rs 2,279 crore in Q1 Ruchika Sharma1 Aug 2025 4:38 PM ISTMumbai: Drugmaker Sun Pharmaceutical Industries reported a 20 percent year-on-year decline in consolidated net profit to Rs 2,279 crore for the...
Sun Pharma unveils Leqselvi in US for severe Alopecia Areata Ruchika Sharma14 July 2025 5:26 PM ISTMumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S. following...
Sun Pharma, Incyte settle dispute over LEQSELVI Ruchika Sharma14 July 2025 4:30 PM ISTMumbai: Sun Pharmaceutical Industries Limited has announced that Sun and Incyte Corporation have entered into a settlement and license agreement...
Socioeconomic Factors May Overshadow Racial Emphasis in Frontal Fibrosing Alopecia: Study Shows Medha Baranwal8 July 2025 9:15 PM ISTUSA: A recent study has revealed that patients with frontal fibrosing alopecia (FFA) are more likely to live in affluent areas, as determined by their...
Baricitinib Shows Long-Term Safety in Severe Alopecia Areata: 4-Year Trial Data Medha Baranwal18 April 2025 9:00 PM ISTUSA: In a significant advancement for the treatment of severe alopecia areata (AA), long-term data from two phase III clinical trials-BRAVE-AA1 and...
Court Removes Injunction on Sun Pharma's LEQSELVI Launch in US Farhat Nasim10 April 2025 6:05 PM ISTDelhi: In a major relief to Sun Pharmaceutical Industries Ltd, the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary injunction...
